Literature DB >> 25394487

Epo-induced erythroid maturation is dependent on Plcγ1 signaling.

T M Schnöder1, P Arreba-Tutusaus1, I Griehl1, L Bullinger2, M Buschbeck3, S W Lane4, K Döhner2, C Plass5, D B Lipka6, F H Heidel1, T Fischer1.   

Abstract

Erythropoiesis is a tightly regulated process. Development of red blood cells occurs through differentiation of hematopoietic stem cells (HSCs) into more committed progenitors and finally into erythrocytes. Binding of erythropoietin (Epo) to its receptor (EpoR) is required for erythropoiesis as it promotes survival and late maturation of erythroid progenitors. In vivo and in vitro studies have highlighted the requirement of EpoR signaling through Janus kinase 2 (Jak2) tyrosine kinase and Stat5a/b as a central pathway. Here, we demonstrate that phospholipase C gamma 1 (Plcγ1) is activated downstream of EpoR-Jak2 independently of Stat5. Plcγ1-deficient pro-erythroblasts and erythroid progenitors exhibited strong impairment in differentiation and colony-forming potential. In vivo, suppression of Plcγ1 in immunophenotypically defined HSCs (Lin(-)Sca1(+)KIT(+)CD48(-)CD150(+)) severely reduced erythroid development. To identify Plcγ1 effector molecules involved in regulation of erythroid differentiation, we assessed changes occurring at the global transcriptional and DNA methylation level after inactivation of Plcγ1. The top common downstream effector was H2afy2, which encodes for the histone variant macroH2A2 (mH2A2). Inactivation of mH2A2 expression recapitulated the effects of Plcγ1 depletion on erythroid maturation. Taken together, our findings identify Plcγ1 and its downstream target mH2A2, as a 'non-canonical' Epo signaling pathway essential for erythroid differentiation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25394487      PMCID: PMC4423181          DOI: 10.1038/cdd.2014.186

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  57 in total

1.  Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation.

Authors:  Yongzhi Cui; Greg Riedlinger; Keiko Miyoshi; Wei Tang; Cuiling Li; Chu-Xia Deng; Gertraud W Robinson; Lothar Hennighausen
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

2.  Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts.

Authors:  M Socolovsky; H Nam; M D Fleming; V H Haase; C Brugnara; H F Lodish
Journal:  Blood       Date:  2001-12-01       Impact factor: 22.113

3.  Absence of erythrogenesis and vasculogenesis in Plcg1-deficient mice.

Authors:  Hong-Jun Liao; Tsutomu Kume; Catriona McKay; Ming-Jiang Xu; James N Ihle; Graham Carpenter
Journal:  J Biol Chem       Date:  2001-12-13       Impact factor: 5.157

4.  Tyrosine residues in bovine phospholipase C-gamma phosphorylated by the epidermal growth factor receptor in vitro.

Authors:  J W Kim; S S Sim; U H Kim; S Nishibe; M I Wahl; G Carpenter; S G Rhee
Journal:  J Biol Chem       Date:  1990-03-05       Impact factor: 5.157

5.  Erythroblast cell lines transformed by a temperature-sensitive mutant of avian erythroblastosis virus: a model system to study erythroid differentiation in vitro.

Authors:  H Beug; G Doederlein; C Freudenstein; T Graf
Journal:  J Cell Physiol Suppl       Date:  1982

6.  Functional activation of the T-cell antigen receptor induces tyrosine phosphorylation of phospholipase C-gamma 1.

Authors:  A Weiss; G Koretzky; R C Schatzman; T Kadlecek
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

7.  Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors.

Authors:  U Klingmüller; H Wu; J G Hsiao; A Toker; B C Duckworth; L C Cantley; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

8.  Regulation of erythropoietin-induced STAT serine phosphorylation by distinct mitogen-activated protein kinases.

Authors:  Rizwan Haq; Adrienne Halupa; Bryan K Beattie; Jacqueline M Mason; Brent W Zanke; Dwayne L Barber
Journal:  J Biol Chem       Date:  2002-03-01       Impact factor: 5.157

9.  In BCR-ABL-positive cells, STAT-5 tyrosine-phosphorylation integrates signals induced by imatinib mesylate and Ara-C.

Authors:  T Kindler; F Breitenbuecher; S Kasper; T Stevens; B Carius; H Gschaidmeier; C Huber; T Fischer
Journal:  Leukemia       Date:  2003-06       Impact factor: 11.528

Review 10.  Mouse embryonic hematopoiesis.

Authors:  E Dzierzak; A Medvinsky
Journal:  Trends Genet       Date:  1995-09       Impact factor: 11.639

View more
  19 in total

1.  Specificity of JAK-kinase inhibition determines impact on human and murine T-cell function.

Authors:  F Perner; T M Schnöder; S Ranjan; D Wolleschak; C Ebert; M C Pils; S Frey; A Polanetzki; C Fahldieck; U Schönborn; B Schraven; B Isermann; T Fischer; F H Heidel
Journal:  Leukemia       Date:  2015-08-05       Impact factor: 11.528

2.  SDF1α-induced chemotaxis of JAK2-V617F-positive cells is dependent on Bruton tyrosine kinase and its downstream targets PI3K/AKT, PLCγ1 and RhoA.

Authors:  Subbaiah Chary Nimmagadda; Stephanie Frey; Peter Müller; Denise Wolleschak; Sönke Weinert; Ulrich Keller; Bärbel Edelmann; Thomas Fischer
Journal:  Haematologica       Date:  2019-02-14       Impact factor: 9.941

3.  Oncogenic JAK2V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms.

Authors:  Alessandro Prestipino; Alica J Emhardt; Konrad Aumann; David O'Sullivan; Sivahari P Gorantla; Sandra Duquesne; Wolfgang Melchinger; Lukas Braun; Slavica Vuckovic; Melanie Boerries; Hauke Busch; Sebastian Halbach; Sandra Pennisi; Teresa Poggio; Petya Apostolova; Pia Veratti; Michael Hettich; Gabriele Niedermann; Mark Bartholomä; Khalid Shoumariyeh; Jonas S Jutzi; Julius Wehrle; Christine Dierks; Heiko Becker; Annette Schmitt-Graeff; Marie Follo; Dietmar Pfeifer; Jan Rohr; Sebastian Fuchs; Stephan Ehl; Frederike A Hartl; Susana Minguet; Cornelius Miething; Florian H Heidel; Nicolaus Kröger; Ioanna Triviai; Tilman Brummer; Jürgen Finke; Anna L Illert; Eliana Ruggiero; Chiara Bonini; Justus Duyster; Heike L Pahl; Steven W Lane; Geoffrey R Hill; Bruce R Blazar; Nikolas von Bubnoff; Erika L Pearce; Robert Zeiser
Journal:  Sci Transl Med       Date:  2018-02-21       Impact factor: 17.956

4.  JAK2-V617F promotes venous thrombosis through β1/β2 integrin activation.

Authors:  Bärbel Edelmann; Nibedita Gupta; Tina M Schnoeder; Anja M Oelschlegel; Khurrum Shahzad; Jürgen Goldschmidt; Lars Philipsen; Soenke Weinert; Aniket Ghosh; Felix C Saalfeld; Subbaiah Chary Nimmagadda; Peter Müller; Rüdiger Braun-Dullaeus; Juliane Mohr; Denise Wolleschak; Stefanie Kliche; Holger Amthauer; Florian H Heidel; Burkhart Schraven; Berend Isermann; Andreas J Müller; Thomas Fischer
Journal:  J Clin Invest       Date:  2018-07-19       Impact factor: 14.808

Review 5.  Emerging EPO and EPO receptor regulators and signal transducers.

Authors:  David Kuhrt; Don M Wojchowski
Journal:  Blood       Date:  2015-04-17       Impact factor: 22.113

6.  Cell autonomous expression of CXCL-10 in JAK2V617F-mutated MPN.

Authors:  Tina M Schnöder; Judith Eberhardt; Michael Koehler; Holger B Bierhoff; Sönke Weinert; Akhilesh Datt Pandey; Subbaiah Chary Nimmagadda; Denise Wolleschak; Korinna Jöhrens; Thomas Fischer; Florian H Heidel
Journal:  J Cancer Res Clin Oncol       Date:  2017-02-23       Impact factor: 4.553

Review 7.  Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis.

Authors:  Nicole Rainville; Edward Jachimowicz; Don M Wojchowski
Journal:  Expert Opin Ther Targets       Date:  2015-09-30       Impact factor: 6.902

8.  Epigenetic mechanisms in health and disease: BCEC 2017.

Authors:  Albert Carbonell; Raquel Fueyo; Andrea Izquierdo-Bouldstridge; Cristina Moreta; Albert Jordan
Journal:  Epigenetics       Date:  2018-02-23       Impact factor: 4.528

9.  PLCG1 is required for AML1-ETO leukemia stem cell self-renewal.

Authors:  Tina M Schnoeder; Adrian Schwarzer; Ashok Kumar Jayavelu; Chen-Jen Hsu; Joanna Kirkpatrick; Konstanze Döhner; Florian Perner; Theresa Eifert; Nicolas Huber; Patricia Arreba-Tutusaus; Anna Dolnik; Salam A Assi; Monica Nafria; Lu Jiang; Yu-Ting Dai; Zhu Chen; Sai-Juan Chen; Sophie G Kellaway; Anetta Ptasinska; Elizabeth S Ng; Edouard G Stanley; Andrew G Elefanty; Marcus Buschbeck; Holger Bierhoff; Steffen Brodt; Georg Matziolis; Klaus-Dieter Fischer; Andreas Hochhaus; Chun-Wei Chen; Olaf Heidenreich; Matthias Mann; Steven W Lane; Lars Bullinger; Alessandro Ori; Björn von Eyss; Constanze Bonifer; Florian H Heidel
Journal:  Blood       Date:  2022-02-17       Impact factor: 25.476

10.  Oncogenic Sox2 regulates and cooperates with VRK1 in cell cycle progression and differentiation.

Authors:  David S Moura; Isabel F Fernández; Gema Marín-Royo; Inmaculada López-Sánchez; Elena Martín-Doncel; Francisco M Vega; Pedro A Lazo
Journal:  Sci Rep       Date:  2016-06-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.